[go: up one dir, main page]

PL400584A1 - Medical use of 3-(thiophen-2-yl)-1,2,4-triazole-5-thione - Google Patents

Medical use of 3-(thiophen-2-yl)-1,2,4-triazole-5-thione

Info

Publication number
PL400584A1
PL400584A1 PL400584A PL40058412A PL400584A1 PL 400584 A1 PL400584 A1 PL 400584A1 PL 400584 A PL400584 A PL 400584A PL 40058412 A PL40058412 A PL 40058412A PL 400584 A1 PL400584 A1 PL 400584A1
Authority
PL
Poland
Prior art keywords
medical use
triazole
thione
thiophen
toxoplasmosis
Prior art date
Application number
PL400584A
Other languages
Polish (pl)
Other versions
PL221182B1 (en
Inventor
Agata Siwek
Katarzyna Dzitko
Original Assignee
Uniwersytet Medyczny W Lublinie
Uniwersytet Łódzki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny W Lublinie, Uniwersytet Łódzki filed Critical Uniwersytet Medyczny W Lublinie
Priority to PL400584A priority Critical patent/PL221182B1/en
Publication of PL400584A1 publication Critical patent/PL400584A1/en
Publication of PL221182B1 publication Critical patent/PL221182B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem wynalazku jest zastosowanie medyczne pochodnej s-triazolu, o wzorze ogólnym 1 do wytwarzania leku przeznaczonego do leczenia toksoplazmozy.The subject of the invention is the medical use of the s-triazole derivative of the general formula 1 for the manufacture of a drug intended for the treatment of toxoplasmosis.

PL400584A 2012-08-30 2012-08-30 Medical use of 3-(thiophen-2-yl)-1,2,4-triazole-5-thione PL221182B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL400584A PL221182B1 (en) 2012-08-30 2012-08-30 Medical use of 3-(thiophen-2-yl)-1,2,4-triazole-5-thione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL400584A PL221182B1 (en) 2012-08-30 2012-08-30 Medical use of 3-(thiophen-2-yl)-1,2,4-triazole-5-thione

Publications (2)

Publication Number Publication Date
PL400584A1 true PL400584A1 (en) 2014-03-03
PL221182B1 PL221182B1 (en) 2016-03-31

Family

ID=50158522

Family Applications (1)

Application Number Title Priority Date Filing Date
PL400584A PL221182B1 (en) 2012-08-30 2012-08-30 Medical use of 3-(thiophen-2-yl)-1,2,4-triazole-5-thione

Country Status (1)

Country Link
PL (1) PL221182B1 (en)

Also Published As

Publication number Publication date
PL221182B1 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
CY1119707T1 (en) DIABLIC AMID CARE UNITS AS MODELS
CY1120703T1 (en) HETEROCYCLE COMPOUNDS AND THEIR USES
CY1120635T1 (en) AMINOETERALYL BENZAMIDS AS KINASE INhibitors
CY1118379T1 (en) DISEASES OF USVITIS C
EA201690020A1 (en) APPLICATION OF PYRAZOLOPIRIDINE DERIVATIVES FOR THE TREATMENT OF URINARY BUBBLE CANCER
MX377916B (en) 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS.
CY1119361T1 (en) 3,4-Dihydroisoquinoline-2 (1H) -Material Compounds
PE20151542A1 (en) TETRAHYDROPYRROTHIAZINE COMPOUNDS
EA201391029A1 (en) OXAZIN DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF NEUROLOGICAL DISORDERS
UY34451A (en) URACILO DERIVATIVES AS INHIBITORS OF THE AXL AND C-MET KINASE
UY34657A (en) ? MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES ?.
CR20150078A (en) 1,4-DISPOSED PIRIDAZINE ANALOGS AND METHODS FOR THE TREATMENT OF CONDITIONS RELATED TO THE DEFICIENCY OF SMN
PE20151788A1 (en) TETRACYCLIC BROMODOMINES INHIBITORS
MX2021005052A (en) Oxysterols and methods of use thereof.
NZ732511A (en) Small molecule inhibitors of egfr and pi3k
EA201591805A1 (en) OXABICICLO [2.2.2] ACIDS - MODULATORS GPR120
NZ704266A (en) Inhibitors of alpha-crystallin aggregation for the treatment for cataract
CR20140052A (en) A NEW NOVELED 1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVE FOR THE TREATMENT OF DIABETES
CY1119118T1 (en) THERAPEUTIC PRODUCTS FOR DISORDERS DISORDERS
CR20150417A (en) AZETIDINYLOXYPHENYLPIRROLIDINE COMPOUNDS
EA201270728A1 (en) PURINE CONNECTIONS
CY1114760T1 (en) Atherosclerosis Therapeutic Treatment
CY1119483T1 (en) THERAPEUTIC PARTY FOR ANXIETY DISORDERS
MX2016015856A (en) DERIVATIVES OF NAFTIRIDINADIONA.
EP2602255A4 (en) FUSED HETEROCYCLIC CYCLE COMPOUND